MINNEAPOLIS – Medtronic, Inc.today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic access. The Medtronic CoreValve ...
Siegburg, Germany - Percutaneous implantation of the self-expanding CoreValve aortic valve bioprosthesis in the first-ever series of patients shows that the procedure is feasible in those deemed too ...
FRESNO, Calif. (KFSN) -- Severe aortic stenosis is a heart condition that happens when the aortic valve doesn't open properly. Patients used to have to undergo an invasive, open-heart surgery to ...
Medtronic says it plans to appeal the $73.5 million jury verdict that its CoreValve transcatheter aortic valve system infringes a U.S. Andersen patent owned by Edwards Lifesciences. The CoreValve ...
The FDA today approved Medtronic's CoreValve transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis who are unable to undergo conventional open-heart surgery.
Edwards Lifesciences and Medtronic have been battling each other for half a dozen years (at least) over a heart valve patent, and recent news suggests Germany's District Court of Mannheim will favor ...
Medtronic's CoreValve transcatheter aortic valve replacement system continued to report positive data at two years for high-risk patients. The study shows the efficacy of TAVR for high-risk patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results